Teva’s strategy: What will it hold, what will it let go?
Teva CEO Jeremy Levin's strategic plan for Teva will be fateful for a string of Israeli biomed development companies.
(photo credit: REUTERS/Ronen Zvulun)
if(catID != 151){
var cont = `Take Israel home with the new
Jerusalem Post Store
Shop now >>
`;
document.getElementById("linkPremium").innerHTML = cont;
var divWithLink = document.getElementById("premium-link");
if(divWithLink !== null && divWithLink !== 'undefined')
{
divWithLink.style.border = "solid 1px #cb0f3e";
divWithLink.style.textAlign = "center";
divWithLink.style.marginBottom = "40px";
divWithLink.style.marginTop = "40px";
divWithLink.style.width = "728px";
divWithLink.style.backgroundColor = "#3c4860";
divWithLink.style.color = "#ffffff";
}
}
(function (v, i){
});